Catherine Fahrner

Transgene (France) FR

Publications

220

Citations

H-Index

i10-Index

1.0

2yr Mean Cite

Cite/Paper

Data combined from OpenAlex + Semantic Scholar. OA = OpenAlex S2 = Semantic Scholar

Verify on Google Scholar

Publication & Citation Trends

Publications

0 total

Immune Checkpoint Blockade, Immunogenic Chemotherapy or IFN-α Blockade Boost the Local and Abscopal Effects of Oncolytic Virotherapy. OA

Laetitia Fend, T. Yamazaki, C. Remy, Catherine Fahrner, M. Gantzer - Cancer Research, 2017

Cited by 108 Semantic Scholar

Vectorization in an oncolytic vaccinia virus of an antibody, a Fab and a scFv against programmed cell death -1 (PD-1) allows their intratumoral delivery and an improved tumor-growth inhibition OA

P. Kleinpeter, Laetitia Fend, C. Thioudellet, M. Geist, Nathalie Sfrontato - Oncoimmunology, 2016

Cited by 91 Semantic Scholar

Research Topics

Virus-based gene therapy research (14) Cytomegalovirus and herpesvirus research (6) CAR-T cell therapy research (6) Viral gastroenteritis research and epidemiology (4) Herpesvirus Infections and Treatments (2)

Affiliations

Transgene (France)

FR 2025 - 2016

External Profiles

OpenAlex Profile Semantic Scholar Profile Google Scholar

Share Profile

Back to Researchers

Catherine Fahrner

Publication & Citation Trends

Publications

Immune Checkpoint Blockade, Immunogenic Chemotherapy or IFN-α Blockade Boost the Local and Abscopal Effects of Oncolytic Virotherapy. OA

Vectorization in an oncolytic vaccinia virus of an antibody, a Fab and a scFv against programmed cell death -1 (PD-1) allows their intratumoral delivery and an improved tumor-growth inhibition OA

Research Topics

Affiliations

External Profiles

Share Profile

Journal Details

Join JournalsHub

Welcome Back